Joshua Rabinowitz
Corporate Officer/Principal at Princeton University
Profile
Dr. Joshua Rabinowitz is Co-Founder at Raze Therapeutics, Inc., a Member at Lewis-Sigler Institute For Integrative Genomics, a Member at The Cancer Institute of New Jersey and a Professor at Princeton University.
He received his undergraduate degree from the University of North Carolina at Chapel Hill and a doctorate degree from Stanford University.
Joshua Rabinowitz active positions
| Companies | Position | Start |
|---|---|---|
| Princeton University | Corporate Officer/Principal | - |
The Cancer Institute of New Jersey
 The Cancer Institute of New Jersey Hospital/Nursing ManagementHealth Services The Cancer Institute of New Jersey operates as a cancer centre. The firm offers cancer care for adults and children, providing access to the medicines and treatment options. It also offers clinical, patient education resources and support services. The company was founded in and is headquartered in New Brunswick, NJ. | Corporate Officer/Principal | - |
| Lewis-Sigler Institute For Integrative Genomics | Corporate Officer/Principal | - |
Former positions of Joshua Rabinowitz
| Companies | Position | End |
|---|---|---|
Raze Therapeutics, Inc.
 Raze Therapeutics, Inc. BiotechnologyHealth Technology Raze Therapeutics, Inc. engages in the discovery and development of oncology therapeutics. It offers a pipeline of one-carbon (1C) metabolism therapeutics across solid and hematologic cancers, including genetically-defined cancers. The company was founded by Vamsi Mootha, Joshua Rabinowitz, David Sabatini, and Adam Friedman on August 8, 2014 and is headquartered in Cambridge, MA. | Founder | - |
Training of Joshua Rabinowitz
| The University of North Carolina at Charlotte | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Raze Therapeutics, Inc.
Raze Therapeutics, Inc. BiotechnologyHealth Technology Raze Therapeutics, Inc. engages in the discovery and development of oncology therapeutics. It offers a pipeline of one-carbon (1C) metabolism therapeutics across solid and hematologic cancers, including genetically-defined cancers. The company was founded by Vamsi Mootha, Joshua Rabinowitz, David Sabatini, and Adam Friedman on August 8, 2014 and is headquartered in Cambridge, MA. | Health Technology |
The Cancer Institute of New Jersey
The Cancer Institute of New Jersey Hospital/Nursing ManagementHealth Services The Cancer Institute of New Jersey operates as a cancer centre. The firm offers cancer care for adults and children, providing access to the medicines and treatment options. It also offers clinical, patient education resources and support services. The company was founded in and is headquartered in New Brunswick, NJ. | Health Services |
| Lewis-Sigler Institute For Integrative Genomics |
- Stock Market
- Insiders
- Joshua Rabinowitz
